What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Koichi Hirata mostly deals with Internal medicine, Cancer, Cancer research, Pathology and Immunology.
His Internal medicine research includes themes of Gastroenterology, Endocrinology and Surgery.
His Gastroenterology research includes elements of Parenteral nutrition and Perioperative.
In his research on the topic of Cancer, Regulation of gene expression is strongly related with Gene expression profiling.
His studies in Cancer research integrate themes in fields like Survivin, Cancer cell, Carcinogenesis, Colorectal cancer and Survival analysis.
His research investigates the connection between Pathology and topics such as Metastasis that intersect with issues in Cisplatin and Chemotherapy.
His most cited work include:
- Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. (396 citations)
- Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. (288 citations)
- Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors (275 citations)
What are the main themes of his work throughout his whole career to date?
Koichi Hirata focuses on Internal medicine, Surgery, Pathology, Cancer and Oncology.
The various areas that Koichi Hirata examines in his Internal medicine study include Gastroenterology and Endocrinology.
His Surgery research incorporates themes from Radiology and General surgery.
His Pathology study frequently links to related topics such as Pancreas.
The study of Cancer is intertwined with the study of Cancer research in a number of ways.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer cell, Pancreatic cancer and Immunology.
He most often published in these fields:
- Internal medicine (32.79%)
- Surgery (19.56%)
- Pathology (15.22%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (32.79%)
- Surgery (19.56%)
- Oncology (12.06%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Surgery, Oncology, Cancer and Pathology.
In Internal medicine, Koichi Hirata works on issues like Gastroenterology, which are connected to Hepatocellular carcinoma.
His research in Surgery intersects with topics in Meta-analysis, Radiology and General surgery.
The Oncology study combines topics in areas such as Regimen and Breast cancer.
His Pathology study integrates concerns from other disciplines, such as Cancer research, Pancreatic cancer and Claudin.
Koichi Hirata combines subjects such as Immunology and Gene knockdown with his study of Cancer research.
Between 2013 and 2021, his most popular works were:
- Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). (273 citations)
- Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. (180 citations)
- Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. (177 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Internal medicine, Surgery, Pathology, Cancer and Cancer research are his primary areas of study.
His Internal medicine research includes elements of Gastroenterology and Oncology.
His Surgery research integrates issues from Hepatocellular carcinoma and General surgery.
When carried out as part of a general Pathology research project, his work on Immunohistochemistry is frequently linked to work in Homogeneous, therefore connecting diverse disciplines of study.
His research integrates issues of Cisplatin and Gene knockdown in his study of Cancer.
His Cancer research research incorporates elements of Pancreatic cancer, Cancer cell, Immunology, Antigen and Cancer immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
